{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T06:44:24Z","timestamp":1767422664261,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T00:00:00Z","timestamp":1628726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T00:00:00Z","timestamp":1628726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s10096-021-04321-3","type":"journal-article","created":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T07:07:10Z","timestamp":1628752030000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical and bacterial features of Group B streptococci with reduced penicillin susceptibility from respiratory specimens: a case\u2013control study"],"prefix":"10.1007","volume":"41","author":[{"given":"Naoya","family":"Nishiyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0262-0401","authenticated-orcid":false,"given":"Takeshi","family":"Kinjo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Uechi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gretchen","family":"Parrott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Nakamatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Tateyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiro","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,12]]},"reference":[{"key":"4321_CR1","unstructured":"Hanley J (2008) Neonatal infections: Group B Streptococcus. BMJ Clin Evid 2008 pii:0323"},{"key":"4321_CR2","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1086\/432804","volume":"41","author":"MS Edwards","year":"2005","unstructured":"Edwards MS, Baker CJ (2005) Group B streptococcal infections in elderly adults. Clin Infect Dis 41:839\u2013847. https:\/\/doi.org\/10.1086\/432804","journal-title":"Clin Infect Dis"},{"key":"4321_CR3","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1097\/AOG.0000000000003668","volume":"135","author":"The American College of Obstetricians and Gynecologists","year":"2020","unstructured":"The American College of Obstetricians and Gynecologists (2020) Prevention of Group B streptococcal early-onset disease in newborns: ACOG committee opinion, number 797. Obstet Gynecol 135:e51\u2013e72. https:\/\/doi.org\/10.1097\/AOG.0000000000003668","journal-title":"Obstet Gynecol"},{"key":"4321_CR4","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1128\/AAC.00185-08","volume":"52","author":"K Kimura","year":"2008","unstructured":"Kimura K, Suzuki S, Wachino J et al (2008) First molecular characterization of Group B streptococci with reduced penicillin susceptibility. Antimicrob Agents Chemother 52:2890\u20132897. https:\/\/doi.org\/10.1128\/AAC.00185-08","journal-title":"Antimicrob Agents Chemother"},{"key":"4321_CR5","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1128\/AAC.00461-08","volume":"52","author":"S Dahesh","year":"2008","unstructured":"Dahesh S, Hensler ME, Van Sorge NM et al (2008) Point mutation in the Group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics. Antimicrob Agents Chemother 52:2915\u20132918. https:\/\/doi.org\/10.1128\/AAC.00461-08","journal-title":"Antimicrob Agents Chemother"},{"key":"4321_CR6","doi-asserted-by":"publisher","first-page":"574.e7","DOI":"10.1016\/j.cmi.2017.02.021","volume":"23","author":"BJ Metcalf","year":"2017","unstructured":"Metcalf BJ, Chochua S, Gertz RE Jr et al (2017) Short-read whole genome sequencing for determination of antimicrobial resistance mechanisms and capsular serotypes of current invasive Streptococcus agalactiae recovered in the USA. Clin Microbiol Infect 23:574.e7-574.e14. https:\/\/doi.org\/10.1016\/j.cmi.2017.02.021","journal-title":"Clin Microbiol Infect"},{"key":"4321_CR7","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1093\/jac\/dkp458","volume":"65","author":"C Gaudreau","year":"2010","unstructured":"Gaudreau C, Lecours R, Isma\u00efl J et al (2010) Prosthetic hip joint infection with a Streptococcus agalactiae isolate not susceptible to penicillin G and ceftriaxone. J Antimicrob Chemother 65:594\u2013595. https:\/\/doi.org\/10.1093\/jac\/dkp458","journal-title":"J Antimicrob Chemother"},{"key":"4321_CR8","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1128\/AAC.01243-10","volume":"55","author":"J Longtin","year":"2011","unstructured":"Longtin J, Vermeiren C, Shahinas D et al (2011) Novel mutations in a patient isolate of Streptococcus agalactiae with reduced penicillin susceptibility emerging after long-term oral suppressive therapy. Antimicrob Agents Chemother 55:2983\u20132985. https:\/\/doi.org\/10.1128\/AAC.01243-10","journal-title":"Antimicrob Agents Chemother"},{"key":"4321_CR9","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1089\/mdr.2017.0013","volume":"23","author":"G Piccinelli","year":"2017","unstructured":"Piccinelli G, Carlentini G, Gargiulo F et al (2017) Analysis of point mutations in the pbp2x, pbp2b, and pbp1a genes of Streptococcus agalactiae and their relation with a reduced susceptibility to cephalosporins. Microb Drug Resist 23:1019\u20131024. https:\/\/doi.org\/10.1089\/mdr.2017.0013","journal-title":"Microb Drug Resist"},{"key":"4321_CR10","doi-asserted-by":"publisher","unstructured":"Siga\u00faque B, Kobayashi M, Vubil D et al (2018) Invasive bacterial disease trends and characterization of Group B streptococcal isolates among young infants in southern Mozambique, 2001-2015. PLoS One 13:e0191193. https:\/\/doi.org\/10.1371\/journal.pone.0191193","DOI":"10.1371\/journal.pone.0191193"},{"key":"4321_CR11","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3343\/alm.2019.39.4.414","volume":"39","author":"A Yi","year":"2019","unstructured":"Yi A, Kim CK, Kimura K et al (2019) First case in Korea of Group B Streptococcus with reduced penicillin susceptibility harboring amino acid substitutions in penicillin-binding protein 2X. Ann Lab Med 39:414\u2013416. https:\/\/doi.org\/10.3343\/alm.2019.39.4.414","journal-title":"Ann Lab Med"},{"key":"4321_CR12","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1093\/jac\/dkz465","volume":"75","author":"M Van Der Linden","year":"2020","unstructured":"Van Der Linden M, Mamede R, Levina N et al (2020) Heterogeneity of penicillin-non-susceptible Group B streptococci isolated from a single patient in Germany. J Antimicrob Chemother 75:296\u2013269. https:\/\/doi.org\/10.1093\/jac\/dkz465","journal-title":"J Antimicrob Chemother"},{"key":"4321_CR13","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1093\/cid\/ciaa151","volume":"72","author":"L McGee","year":"2021","unstructured":"McGee L, Chochua S, Li Z et al (2021) Multistate, population-based distributions of candidate vaccine targets, clonal complexes, and resistance features of invasive Group B streptococci within the United States, 2015\u20132017. Clin Infect Dis 72:1004\u20131013. https:\/\/doi.org\/10.1093\/cid\/ciaa151","journal-title":"Clin Infect Dis"},{"key":"4321_CR14","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1093\/jac\/dkv203","volume":"70","author":"T Seki","year":"2015","unstructured":"Seki T, Kimura K, Reid ME et al (2015) High isolation rate of MDR Group B streptococci with reduced penicillin susceptibility in Japan. J Antimicrob Chemother 70:2725\u20132728. https:\/\/doi.org\/10.1093\/jac\/dkv203","journal-title":"J Antimicrob Chemother"},{"key":"4321_CR15","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1093\/jac\/dkr352","volume":"66","author":"K Kimura","year":"2011","unstructured":"Kimura K, Nagano N, Nagano Y et al (2011) Predominance of sequence type 1 Group with serotype VI among Group B streptococci with reduced penicillin susceptibility identified in Japan. J Antimicrob Chemother 66:2460\u20132464. https:\/\/doi.org\/10.1093\/jac\/dkr352","journal-title":"J Antimicrob Chemother"},{"key":"4321_CR16","unstructured":"The Committee for the JRS Guidelines in the Management of Respiratory Infections in Adults (2017) The JRS guidelines for the management of pneumonia in adults. Tokyo, 34\u201348 (Article in Japanese)"},{"key":"4321_CR17","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"M Oken","year":"1982","unstructured":"Oken M, Creech R, Tormey D et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649\u2013655","journal-title":"Am J Clin Oncol"},{"key":"4321_CR18","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1128\/JCM.41.6.2530-2536.2003","volume":"41","author":"N Jones","year":"2003","unstructured":"Jones N, Bohnsack J, Takahashi S et al (2003) Multilocus sequence typing system for Group B streptococcus. J Clin Microbiol 41:2530\u20132536. https:\/\/doi.org\/10.1128\/JCM.41.6.2530-2536.2003","journal-title":"J Clin Microbiol"},{"key":"4321_CR19","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1093\/jac\/dkr546","volume":"67","author":"N Nagano","year":"2012","unstructured":"Nagano N, Nagano Y, Toyama M et al (2012) Nosocomial spread of multidrug-resistant Group B streptococci with reduced penicillin susceptibility belonging to clonal complex 1. J Antimicrob Chemother 67:849\u2013856. https:\/\/doi.org\/10.1093\/jac\/dkr546","journal-title":"J Antimicrob Chemother"},{"key":"4321_CR20","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1007\/s10096-018-3278-7","volume":"37","author":"H Banno","year":"2018","unstructured":"Banno H, Kimura K, Seki T et al (2018) High isolation rate and multidrug resistance tendency of penicillin-susceptible Group B Streptococcus with reduced ceftibuten susceptibility in Japan. Eur J Clin Microbiol Infect Dis 37:1511\u20131519. https:\/\/doi.org\/10.1007\/s10096-018-3278-7","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4321_CR21","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1056\/NEJMra1714562","volume":"380","author":"LA Mandell","year":"2019","unstructured":"Mandell LA, Niederman MS (2019) Aspiration pneumonia. N Engl J Med 380:651\u2013663. https:\/\/doi.org\/10.1056\/NEJMra1714562","journal-title":"N Engl J Med"},{"key":"4321_CR22","first-page":"1501","volume":"45","author":"T Shiraishi","year":"2009","unstructured":"Shiraishi T, Sakamoto A, Iwatake S et al (2009) A survey of antibiotic treatment for aspiration pneumonia. J Jpn Soc Hosp Pharm 45:1501\u20131504","journal-title":"J Jpn Soc Hosp Pharm"},{"key":"4321_CR23","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1093\/jac\/dkw500","volume":"72","author":"R Taniguchi","year":"2017","unstructured":"Taniguchi R, Kimura K, Miyazaki A et al (2017) High rate of slowly-killed-by-ampicillin phenotype among Group B streptococci with reduced penicillin susceptibility. J Antimicrob Chemother 72:941\u2013942. https:\/\/doi.org\/10.1093\/jac\/dkw500","journal-title":"J Antimicrob Chemother"},{"key":"4321_CR24","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1086\/599369","volume":"49","author":"T Skoff","year":"2009","unstructured":"Skoff T, Farley M, Petit S et al (2009) Increasing burden of invasive Group B streptococcal disease in nonpregnant adults, 1990\u20132007. Clin Infect Dis 49:85\u201392. https:\/\/doi.org\/10.1086\/599369","journal-title":"Clin Infect Dis"},{"key":"4321_CR25","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1001\/archinte.1982.00340220056012","volume":"142","author":"A Verghese","year":"1982","unstructured":"Verghese A, Berk SL, Boelen LJ et al (1982) Group B streptococcal pneumonia in the elderly. Arch Intern Med 142:1642\u20131645","journal-title":"Arch Intern Med"},{"key":"4321_CR26","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ijantimicag.2018.11.003","volume":"53","author":"N Nagano","year":"2019","unstructured":"Nagano N, Koide S, Hayashi W et al (2019) Population-level transition of capsular polysaccharide types among sequence type 1 Group B Streptococcus isolates with reduced penicillin susceptibility during a long-term hospital epidemic. Int J Antimicrob Agents 53:203\u2013210. https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.11.003","journal-title":"Int J Antimicrob Agents"},{"key":"4321_CR27","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/jac\/dks423","volume":"68","author":"K Kimura","year":"2013","unstructured":"Kimura K, Nagano N, Nagano Y et al (2013) High frequency of fluoroquinolone- and macrolide-resistant streptococci among clinically isolated Group B streptococci with reduced penicillin susceptibility. J Antimicrob Chemother 68:539\u2013542. https:\/\/doi.org\/10.1093\/jac\/dks423","journal-title":"J Antimicrob Chemother"},{"key":"4321_CR28","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1128\/AAC.01716-08","volume":"53","author":"SY Maruyama","year":"2009","unstructured":"Maruyama SY, Seki C, Sakata H et al (2009) Capsular type and antibiotic resistance in Streptococcus agalactiae isolates from patients, ranging from newborns to the elderly, with invasive infections. Antimicrob Agents Chemother 53:2650\u20132653. https:\/\/doi.org\/10.1128\/AAC.01716-08","journal-title":"Antimicrob Agents Chemother"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-021-04321-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-021-04321-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-021-04321-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T14:21:56Z","timestamp":1641392516000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-021-04321-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,12]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["4321"],"URL":"https:\/\/doi.org\/10.1007\/s10096-021-04321-3","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"type":"print","value":"0934-9723"},{"type":"electronic","value":"1435-4373"}],"subject":[],"published":{"date-parts":[[2021,8,12]]},"assertion":[{"value":"30 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}